| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 21 |
| 1 | TACROLIMUS | 20 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 20 |
| 3 | TACROLIMUS OINTMENT 0.1% | 20 |
| 4 | OXALIPLATIN | 13 |
| 5 | CIPROFLOXACIN | 12 |
| 6 | CIPROFLOXACIN HYDROCHLORIDE | 12 |
| 7 | CIPROFLOXACIN TABLETS | 12 |
| 8 | CIPROFOLXACIN | 12 |
| 9 | PREDNISONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUTIMLIMAB-JOME | 1 | 0.0031 |
| 1 | RITUXIMAB-ABBS | 10 | 0.0020 |
| 2 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 3 | HUMAN RHO(D) IMMUNE GLOBULIN | 1 | 0.0010 |
| 4 | WHITE PETROLATUM | 1 | 0.0007 |
| 5 | SENNOSIDES A AND B | 1 | 0.0006 |
| 6 | ETRASIMOD | 1 | 0.0006 |
| 7 | PEGCETACOPLAN | 1 | 0.0005 |
| 8 | BRODALUMAB | 1 | 0.0005 |
| 9 | CIMETIDINE | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 4 | 0.0003 |
| 4 | Antiparasitic [EPC] | 1 | 0.0002 |
| 5 | Pediculicide [EPC] | 1 | 0.0002 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |
| 7 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 13 | 0.0001 |